We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

71 hedge funds and large institutions have $776M invested in Beam Therapeutics in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

150% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 10

59% more capital invested

Capital invested by funds: $489M → $776M (+$287M)

18% more funds holding

Funds holding: 60 → 71 (+11)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.87% less ownership

Funds ownership: 54.68% → 53.81% (-0.87%)

Holders
71
Holders Change
+11
Holders Change %
+18.33%
% of All Funds
1.46%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
19
Increased
25
Reduced
10
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$23.1M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.19M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.99M
4
Millennium Management
Millennium Management
New York
+$2.71M
5
BlackRock
BlackRock
New York
+$1.52M

Top Sellers

1
Victory Capital Management
Victory Capital Management
Texas
-$8.87M
2
Franklin Resources
Franklin Resources
California
-$5.41M
3
SFM
Sphera Funds Management
Israel
-$4.76M
4
FCM
Farallon Capital Management
California
-$3.06M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$2.31M +$1.3M +60,223 +269%
Charles Schwab
27
Charles Schwab
California
$2.31M +$1.22M +56,597 +218%
N
28
Nuveen
North Carolina
$1.73M +$336K +15,581 +34%
JP Morgan Chase
29
JP Morgan Chase
New York
$1.15M +$16K +743 +2%
AllianceBernstein
30
AllianceBernstein
Tennessee
$804K +$379K +17,600 +159%
Swiss National Bank
31
Swiss National Bank
Switzerland
$801K +$616K +28,600 New
Ensign Peak Advisors
32
Ensign Peak Advisors
Utah
$797K -$133K -6,154 -18%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$760K +$585K +27,149 New
Citadel Advisors
34
Citadel Advisors
Florida
$759K -$1.28M -59,173 -69%
LCM
35
Laurion Capital Management
New York
$700K – – –
Morgan Stanley
36
Morgan Stanley
New York
$579K +$410K +19,004 +1,121%
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$532K – – –
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$523K – – –
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$496K +$239K +11,100 +168%
Federated Hermes
40
Federated Hermes
Pennsylvania
$492K +$378K +17,554 New
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$410K +$63.7K +2,954 +25%
Wells Fargo
42
Wells Fargo
California
$407K +$143K +6,640 +84%
BM
43
Brandywine Managers
Delaware
$305K -$95.4K -4,425 -29%
Osaic Holdings
44
Osaic Holdings
Arizona
$253K +$194K +9,025 New
Bank of America
45
Bank of America
North Carolina
$243K +$46.4K +2,154 +33%
Norges Bank
46
Norges Bank
Norway
$233K -$252K -11,676 -58%
Squarepoint
47
Squarepoint
New York
$232K +$179K +8,300 New
AIG
48
American International Group
New York
$211K +$5.63K +261 +4%
UBS Group
49
UBS Group
Switzerland
$203K +$139K +6,435 +804%
TD Asset Management
50
TD Asset Management
Ontario, Canada
$201K +$155K +7,176 New
1
2
3 4

BEAM Hedge Fund Activity: Q2 2020 in Review

71 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q2 2020, worth a combined $776M — up 59% from $489M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new BEAM positions and 7 closed out — a net gain of 12 holders — while 25 added to existing stakes and 10 trimmed.

The largest buyer was Vanguard Group, adding an estimated $23.1M. The largest seller was Victory Capital Management, cutting an estimated $8.87M.

  • 71 institutional investors held Beam Therapeutics (BEAM) as of Q2 2020, up from 60 in Q1 2020.
  • Funds reported $776M of Beam Therapeutics stock for Q2 2020, up 59% quarter-over-quarter.
  • 19 funds opened new Beam Therapeutics positions in Q2 2020 and 7 closed out, a net change of +12 holders.
  • The largest Beam Therapeutics buyer in Q2 2020 was Vanguard Group, an estimated $23.1M added.
  • The largest Beam Therapeutics seller in Q2 2020 was Victory Capital Management, an estimated $8.87M sold.

Based on aggregated 13F filings for Q2 2020.